The following Structured Product Label (SPL) was submitted to the FDA by Central Packaging for the product Ondansetron (NDC 80175-0017). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding dosage forms & strengths, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Ondansetron Tablets USP, are available in the following strengths:4 mg – white, oval, film-coated tablets engraved with "4" on one side and “NO”on other side.8 mg – yellow, oval, film-coated tablets engraved with "8" on one side and "NO" on the other side.
* Please review the disclaimer below.
